ARNA Genomics was established
Seed round; Development of ARNA-Thermometr, a test for the presence of oncological diseases; “Know-how” objects formalization
Development of ARNA Breast Cancer — a high-precision test for early detection of breast cancer
Development of ARNA Colon Cancer; ARNA BC development is completed; Beginning of laboratory tests of ARNA BC; Submission of patent application No 1
End of laboratory tests of ARNA BC; Start of ARNA BC clinical research jointly with Sechenov University; Submission of application of Patent Cooperation Treaty No 1; Token Distribution Event
- Opening of the office and the 1st laboratory unit in the USA. - Submission of application of Patent Cooperation Treaty No 2 and 3. - Agreement of the regulatory strategy for ARNA BC. Launch of clinical research No 1 in the USA with FDA. - ARNA CC development is completed, starting laboratory research. - ARNA Panacea – launch of the beta version of blockchain-ecosystem, basic documentation for develop
- Using of ARNA Panacea’s blockchain ecosystem by interested market players (regulators, investors, users, etc.) - Start of development: ARNA Lung, ARNA Liver, ARNA Pancreas; - ARNA BC’s entry into the US market; - Clinical trials in China; - National phases: USA, China, India, EU, UK, Israel, Brazil; - Seed round B; - Receiving the first revenue.
Put this code to your website